🚀 VC round data is live in beta, check it out!
Nakanishi Overview
About Nakanishi
Nakanishi Inc manufactures high-speed rotary cutting technology for the dental industry and the medical industry more broadly. The company distributes its products to countries internationally, earning most of its revenue overseas. The company operates via three business segments. The dental product segment manufactures and sells handpieces for dental treatment, mechanical micro motors and handpieces as well as handpieces for surgeries. The industrial product segment manufactures and sells grinders for manual works and spindles for machinery attachment. The others segment provides inspection and repair services for its dental and medical equipment and general industrial cutting and grinding equipment.
Founded
1981
HQ
Employees
1.4K
Website
Financials (LTM)
EV
$1B
Nakanishi Financials
Nakanishi reported last 12-month revenue of $542M and EBITDA of $132M.
In the same LTM period, Nakanishi generated $307M in gross profit, $132M in EBITDA, and $11M in net income.
Revenue (LTM)
Nakanishi P&L
In the most recent fiscal year, Nakanishi reported revenue of $530M and EBITDA of $130M.
Nakanishi expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $542M | XXX | $530M | XXX | XXX | XXX |
| Gross Profit | $307M | XXX | $290M | XXX | XXX | XXX |
| Gross Margin | 57% | XXX | 55% | XXX | XXX | XXX |
| EBITDA | $132M | XXX | $130M | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 25% | XXX | XXX | XXX |
| EBIT Margin | 18% | XXX | 17% | XXX | XXX | XXX |
| Net Profit | $11M | XXX | ($15M) | XXX | XXX | XXX |
| Net Margin | 2% | XXX | (3%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Nakanishi Stock Performance
Nakanishi has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Nakanishi's stock price is $17.78.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | 0.3% | XXX | XXX | XXX | $-0.18 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNakanishi Valuation Multiples
Nakanishi trades at 2.3x EV/Revenue multiple, and 9.4x EV/EBITDA.
EV / Revenue (LTM)
Nakanishi Financial Valuation Multiples
As of April 19, 2026, Nakanishi has market cap of $1B and EV of $1B.
Equity research analysts estimate Nakanishi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nakanishi has a P/E ratio of 134.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 2.3x | XXX | 2.4x | XXX | XXX | XXX |
| EV/EBITDA | 9.4x | XXX | 9.6x | XXX | XXX | XXX |
| EV/EBIT | 13.1x | XXX | 13.6x | XXX | XXX | XXX |
| EV/Gross Profit | 4.1x | XXX | 4.3x | XXX | XXX | XXX |
| P/E | 134.4x | XXX | (97.7x) | XXX | XXX | XXX |
| EV/FCF | 23.9x | XXX | 17.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Nakanishi Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Nakanishi Margins & Growth Rates
Nakanishi's revenue in the last 12 month grew by 7%.
Nakanishi's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Nakanishi's rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nakanishi's rule of X is 53% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Nakanishi Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 25% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 6% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 36% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 53% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 38% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Nakanishi Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Nakanishi | XXX | XXX | XXX | XXX | XXX | XXX |
| NovoCure | XXX | XXX | XXX | XXX | XXX | XXX |
| AtriCure | XXX | XXX | XXX | XXX | XXX | XXX |
| Savaria | XXX | XXX | XXX | XXX | XXX | XXX |
| Enovis | XXX | XXX | XXX | XXX | XXX | XXX |
| Wandong Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nakanishi M&A Activity
Nakanishi acquired XXX companies to date.
Last acquisition by Nakanishi was on XXXXXXXX, XXXXX. Nakanishi acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Nakanishi
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNakanishi Investment Activity
Nakanishi invested in XXX companies to date.
Nakanishi made its latest investment on XXXXXXXX, XXXXX. Nakanishi invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Nakanishi
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Nakanishi
| When was Nakanishi founded? | Nakanishi was founded in 1981. |
| Where is Nakanishi headquartered? | Nakanishi is headquartered in Japan. |
| How many employees does Nakanishi have? | As of today, Nakanishi has over 1K employees. |
| Who is the CEO of Nakanishi? | Nakanishi's CEO is Eiichi Nakanishi. |
| Is Nakanishi publicly listed? | Yes, Nakanishi is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Nakanishi? | Nakanishi trades under 7716 ticker. |
| When did Nakanishi go public? | Nakanishi went public in 2013. |
| Who are competitors of Nakanishi? | Nakanishi main competitors are NovoCure, AtriCure, Savaria, Enovis. |
| What is the current market cap of Nakanishi? | Nakanishi's current market cap is $1B. |
| What is the current revenue of Nakanishi? | Nakanishi's last 12 months revenue is $542M. |
| What is the current revenue growth of Nakanishi? | Nakanishi revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Nakanishi? | Current revenue multiple of Nakanishi is 2.3x. |
| Is Nakanishi profitable? | Yes, Nakanishi is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Nakanishi? | Nakanishi's last 12 months EBITDA is $132M. |
| What is Nakanishi's EBITDA margin? | Nakanishi's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of Nakanishi? | Current EBITDA multiple of Nakanishi is 9.4x. |
| What is the current FCF of Nakanishi? | Nakanishi's last 12 months FCF is $52M. |
| What is Nakanishi's FCF margin? | Nakanishi's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of Nakanishi? | Current FCF multiple of Nakanishi is 23.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.